# Buprenorphine and Naloxone

NDC: 62175-452
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20160919

FDA application: ANDA205022

## Active ingredients

- BUPRENORPHINE: 2 mg/1
- NALOXONE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62175-452"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62175-452
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14eaa94a-cc8a-4e1e-8cfb-5c976c96c606